Neonatal and early-onset diabetes in Ukraine: Atypical features and mortality

Evgenia Globa1, Nataliya Zelinska1, Matthew B Johnson2

  • 1Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv, Ukraine.

Insights

Genetic testing identified the causes of most neonatal diabetes cases in Ukraine. Rare genetic subtypes were linked to a high mortality rate in infants diagnosed before six months of age.

Area of Science:

  • Pediatric Endocrinology
  • Medical Genetics
  • Neonatology

Background:

  • Neonatal and early-onset diabetes are rare conditions with diverse genetic causes.
  • Accurate diagnosis is crucial for appropriate management and understanding prognosis.
  • Genetic testing has become increasingly important in identifying specific subtypes of pediatric diabetes.

Purpose of the Study:

  • To investigate the genetic aetiology and clinical characteristics of neonatal and early-onset diabetes in Ukrainian children.
  • To identify the prevalence of different genetic subtypes in this cohort.
  • To assess the mortality rate associated with these conditions.

Main Methods:

  • Established a Pediatric Diabetes Register for patients diagnosed before 9 months of age.
  • Conducted genetic testing on 66 patients from 65 families with diabetes diagnosed within the first 9 months of life.
  • Classified patients into neonatal diabetes (diagnosed before 6 months) and early-onset diabetes (diagnosed between 6-9 months).

Main Results:

  • Determined genetic aetiology in 86.1% of neonatal diabetes and 20% of early-onset diabetes cases.
  • Identified common variants in ABCC8, KCNJ11, INS, GCK, and 6q24 transient neonatal diabetes.
  • Discovered rare genetic subtypes in 24.3% of solved cases, with a high mortality rate (6/9) among these.
  • Observed that all eight childhood deaths occurred in patients diagnosed before 6 months with a genetic diagnosis.

Conclusions:

  • Comprehensive genetic testing has improved the recognition of rare genetic diabetes subtypes in pediatric populations.
  • A significant proportion of neonatal diabetes cases have identifiable genetic causes.
  • Rare genetic subtypes of neonatal diabetes are associated with a high mortality rate, highlighting the need for early diagnosis and specialized care.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
648
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
311
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
224